Artificial Retina Gets September FDA Panel Date
This article was originally published in The Gray Sheet
Executive Summary
A humanitarian device exemption application submitted by Second Sight Medical Products for its Argus II retinal prosthesis system will be considered by FDA’s Ophthalmic Devices Panel.